Rein Therapeutics (RNTX) Total Liabilities

Annual Total Liabilities

$99.12 M
+$95.74 M+2829.11%

December 1, 2023


Summary


Performance

RNTX Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherRNTXbalance sheetmetrics:

Quarterly Total Liabilities

$53.99 M
+$606.00 K+1.14%

September 1, 2024


Summary


Performance

RNTX Quarterly Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherRNTXbalance sheetmetrics:

Total Liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

RNTX Total Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+2829.1%-0.8%
3 y3 years+2271.9%+1772.0%
5 y5 years+825.3%+384.8%

RNTX Total Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high-96.6%-45.5%-97.8%
5 y5-yearat high-96.6%-45.5%-97.8%
alltimeall time-25.9%-96.6%-60.3%-97.8%

Rein Therapeutics Total Liabilities History

DateAnnualQuarterly
Sep 2024
-
$53.99 M(+1.1%)
Jun 2024
-
$53.38 M(-1.9%)
Mar 2024
-
$54.44 M(-45.1%)
Dec 2023
$99.12 M(+2829.1%)
$99.12 M(+6003.5%)
Sep 2023
-
$1.62 M(+35.7%)
Jun 2023
-
$1.20 M(-58.5%)
Mar 2023
-
$2.88 M(-14.8%)
Dec 2022
$3.38 M(-26.1%)
$3.38 M(-25.4%)
Sep 2022
-
$4.54 M(-11.9%)
Jun 2022
-
$5.15 M(+24.2%)
Mar 2022
-
$4.15 M(-9.4%)
Dec 2021
$4.58 M(+9.5%)
$4.58 M(-1.8%)
Sep 2021
-
$4.66 M(+5.9%)
Jun 2021
-
$4.40 M(+35.3%)
Mar 2021
-
$3.25 M(-22.2%)
Dec 2020
$4.18 M
$4.18 M(-57.3%)
DateAnnualQuarterly
Sep 2020
-
$9.78 M(+3.3%)
Jun 2020
-
$9.47 M(-10.7%)
Mar 2020
-
$10.60 M(+1.7%)
Dec 2019
$10.43 M(-2.7%)
$10.43 M(-6.4%)
Sep 2019
-
$11.14 M(+9.1%)
Jun 2019
-
$10.21 M(+6.9%)
Mar 2019
-
$9.55 M(-10.8%)
Dec 2018
$10.71 M(+119.0%)
$10.71 M(-11.5%)
Sep 2018
-
$12.10 M(+24.6%)
Jun 2018
-
$9.71 M(+99.9%)
Mar 2018
-
$4.86 M(-0.7%)
Dec 2017
$4.89 M(-96.3%)
$4.89 M(-2.6%)
Sep 2017
-
$5.02 M(-96.3%)
Jun 2017
-
$135.88 M(+4626.4%)
Mar 2017
-
$2.88 M(-97.9%)
Dec 2016
$133.83 M(+33.5%)
$133.83 M
Dec 2015
$100.26 M
-

FAQ

  • What is Rein Therapeutics annual total liabilities?
  • What is the all time high annual total liabilities for Rein Therapeutics?
  • What is Rein Therapeutics annual total liabilities year-on-year change?
  • What is Rein Therapeutics quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Rein Therapeutics?
  • What is Rein Therapeutics quarterly total liabilities year-on-year change?

What is Rein Therapeutics annual total liabilities?

The current annual total liabilities of RNTX is $99.12 M

What is the all time high annual total liabilities for Rein Therapeutics?

Rein Therapeutics all-time high annual total liabilities is $133.83 M

What is Rein Therapeutics annual total liabilities year-on-year change?

Over the past year, RNTX annual total liabilities has changed by +$95.74 M (+2829.11%)

What is Rein Therapeutics quarterly total liabilities?

The current quarterly total liabilities of RNTX is $53.99 M

What is the all time high quarterly total liabilities for Rein Therapeutics?

Rein Therapeutics all-time high quarterly total liabilities is $135.88 M

What is Rein Therapeutics quarterly total liabilities year-on-year change?

Over the past year, RNTX quarterly total liabilities has changed by -$452.00 K (-0.83%)